Peptide And Oligonucleotide CDMO Market Is Anticipated To Expand At A Compound Annual Growth Rate (cagr) From 2024 To 2033
The peptide and oligonucleotide CDMO market is anticipated to expand from $4.5 billion in 2023 to $10.2 billion by 2033, with a CAGR of 8.5%. The Peptide …
